Jim Simons Corcept Therapeutics Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 6,266,402 shares of CORT stock, worth $536 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

6,266,402

Previous 6,143,031 2.01%

Holding current value

$536 Million

Previous $702 Million 34.45%

% of portfolio

0.65%

Previous 1.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$62.24 - $91.93 $7.68 Million - $11.3 Million	123,371 Added 2.01%	6,266,402 $460 Million
Q1 2025 May 14, 2025	SELL	$49.85 - $114.22 $2.77 Million - $6.35 Million	-55,571 Reduced 0.9%	6,143,031 $702 Million
Q4 2024 Feb 13, 2025	SELL	$44.66 - $60.85 $13.9 Million - $18.9 Million	-310,400 Reduced 4.77%	6,198,602 $312 Million
Q3 2024 Nov 13, 2024	SELL	$29.51 - $46.26 $11.9 Million - $18.7 Million	-403,569 Reduced 5.84%	6,509,002 $301 Million
Q2 2024 Aug 09, 2024	SELL	$22.21 - $34.48 $4.57 Million - $7.1 Million	-205,800 Reduced 2.89%	6,912,571 $225 Million
Q1 2024 May 13, 2024	BUY	$21.1 - $27.46 $8.28 Million - $10.8 Million	392,500 Added 5.84%	7,118,371 $179 Million
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $2.76 Million - $3.65 Million	111,000 Added 1.68%	6,725,871 $218 Million
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $1.87 Million - $2.88 Million	-85,100 Reduced 1.27%	6,614,871 $180 Million
Q2 2023 Aug 11, 2023	SELL	$21.44 - $25.15 $1.89 Million - $2.22 Million	-88,098 Reduced 1.3%	6,699,971 $149 Million
Q1 2023 May 12, 2023	SELL	$19.2 - $24.47 $9.62 Million - $12.3 Million	-500,802 Reduced 6.87%	6,788,069 $147 Million
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $1.82 Million - $2.74 Million	91,400 Added 1.27%	7,288,871 $148 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $15.7 Million - $18.5 Million	-636,400 Reduced 8.12%	7,197,471 $185 Million
Q2 2022 Aug 12, 2022	BUY	$17.33 - $25.3 $1.1 Million - $1.6 Million	63,355 Added 0.82%	7,833,871 $186 Million
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $4.18 Million - $6.38 Million	-253,100 Reduced 3.15%	7,770,516 $175 Million
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $3.83 Million - $5.23 Million	-224,225 Reduced 2.72%	8,023,616 $159 Million
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $5.4 Million - $6.18 Million	-274,355 Reduced 3.22%	8,247,841 $162 Million
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $5.02 Million - $6.15 Million	-251,600 Reduced 2.87%	8,522,196 $187 Million
Q1 2021 May 13, 2021	SELL	$23.49 - $30.56 $13.3 Million - $17.3 Million	-567,700 Reduced 6.08%	8,773,796 $209 Million
Q4 2020 Feb 10, 2021	SELL	$16.78 - $27.3 $4.44 Million - $7.22 Million	-264,500 Reduced 2.75%	9,341,496 $244 Million
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $8.55 Million - $13.7 Million	686,000 Added 7.69%	9,605,996 $167 Million
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $6.79 Million - $11.3 Million	617,155 Added 7.43%	8,919,996 $150 Million
Q1 2020 May 14, 2020	BUY	$10.11 - $14.04 $5.41 Million - $7.51 Million	534,627 Added 6.88%	8,302,841 $98.7 Million
Q4 2019 Feb 13, 2020	BUY	$12.06 - $16.96 $15 Million - $21.1 Million	1,244,005 Added 19.07%	7,768,214 $94 Million
Q3 2019 Nov 13, 2019	BUY	$10.41 - $14.66 $9.72 Million - $13.7 Million	933,700 Added 16.7%	6,524,209 $92.2 Million
Q2 2019 Aug 12, 2019	BUY	$9.78 - $12.76 $5.21 Million - $6.8 Million	532,700 Added 10.53%	5,590,509 $62.3 Million
Q1 2019 May 14, 2019	BUY	$10.03 - $15.71 $4.12 Million - $6.45 Million	410,600 Added 8.84%	5,057,809 $59.4 Million
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $52.5 Million - $79.9 Million	4,647,209 New	4,647,209 $62.1 Million

Others Institutions Holding CORT

# of Institutions

467

Shares Held

82.8M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $9.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account